| Woodmont Health Campus | |
| 1325 Rockport Rd, Boonville, Indiana 47601 | |
| (812) 897-4114 | |
| Name | Woodmont Health Campus |
|---|---|
| Location | 1325 Rockport Rd, Boonville, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 50.33% |
| Medicare ID (CCN) | 155682 |
| Legal Business Name | Good Samaritan Hospital |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1063599140 |
| Organization Name | GOOD SAMARITAN HOSPITAL |
| Doing Business As | WOODMONT HEALTH CAMPUS |
| Address | 1325 N Rockport Rd, Boonville, IN 47601 |
| Phone Number | 812-897-4114 |
News Archive
Perrigo Company today announced that it has signed a definitive merger agreement to acquire PBM Holdings, Inc. (PBM), the leading store-brand infant formula manufacturer, for approximately $808 million in cash. Based in Gordonsville, Virginia, privately-held PBM manufactures and distributes over-the-counter store brand infant formula and baby foods sold by leading retailers in the mass, club, grocery and drug channels in the United States, Canada, Mexico and China. The acquisition is expected to close in the Company's fiscal 2010 fourth quarter pending regulatory approval.
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.
The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.
Discovery by Hebrew University of Jerusalem researchers of an additional role for a key molecule in our bodies provides a further step in world-wide efforts to develop genetic regulation aimed at controlling many diseases, including AIDS and various types of cancers.
AIDS Healthcare Foundation (AHF) today announced that it is has named Homayoon Khanlou, M.D. as its Chief of Medicine, U.S. Prior to assuming his new role as Chief, Dr. Khanlou served as AHF's Associate Director of Medicine, Regional Medical Director of Western Region while also holding the posts of AHF's Associate Director of Research and the Medical Director and attending physician for the San Fernando Valley and Antelope Valley Healthcare Centers. Dr. Khanlou has also served as Chair of the Pharmacy and Therapeutic Committee at AHF.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Perrigo Company today announced that it has signed a definitive merger agreement to acquire PBM Holdings, Inc. (PBM), the leading store-brand infant formula manufacturer, for approximately $808 million in cash. Based in Gordonsville, Virginia, privately-held PBM manufactures and distributes over-the-counter store brand infant formula and baby foods sold by leading retailers in the mass, club, grocery and drug channels in the United States, Canada, Mexico and China. The acquisition is expected to close in the Company's fiscal 2010 fourth quarter pending regulatory approval.
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.
The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.
Discovery by Hebrew University of Jerusalem researchers of an additional role for a key molecule in our bodies provides a further step in world-wide efforts to develop genetic regulation aimed at controlling many diseases, including AIDS and various types of cancers.
AIDS Healthcare Foundation (AHF) today announced that it is has named Homayoon Khanlou, M.D. as its Chief of Medicine, U.S. Prior to assuming his new role as Chief, Dr. Khanlou served as AHF's Associate Director of Medicine, Regional Medical Director of Western Region while also holding the posts of AHF's Associate Director of Research and the Medical Director and attending physician for the San Fernando Valley and Antelope Valley Healthcare Centers. Dr. Khanlou has also served as Chair of the Pharmacy and Therapeutic Committee at AHF.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 26.53 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.33 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 29.31 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.85 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.3 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.63 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.26 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.23 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 24.81 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 79.23 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.12 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.11 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 41.18 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.21 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 81.14 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.78 | 82.93 |
News Archive
Perrigo Company today announced that it has signed a definitive merger agreement to acquire PBM Holdings, Inc. (PBM), the leading store-brand infant formula manufacturer, for approximately $808 million in cash. Based in Gordonsville, Virginia, privately-held PBM manufactures and distributes over-the-counter store brand infant formula and baby foods sold by leading retailers in the mass, club, grocery and drug channels in the United States, Canada, Mexico and China. The acquisition is expected to close in the Company's fiscal 2010 fourth quarter pending regulatory approval.
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.
The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.
Discovery by Hebrew University of Jerusalem researchers of an additional role for a key molecule in our bodies provides a further step in world-wide efforts to develop genetic regulation aimed at controlling many diseases, including AIDS and various types of cancers.
AIDS Healthcare Foundation (AHF) today announced that it is has named Homayoon Khanlou, M.D. as its Chief of Medicine, U.S. Prior to assuming his new role as Chief, Dr. Khanlou served as AHF's Associate Director of Medicine, Regional Medical Director of Western Region while also holding the posts of AHF's Associate Director of Research and the Medical Director and attending physician for the San Fernando Valley and Antelope Valley Healthcare Centers. Dr. Khanlou has also served as Chair of the Pharmacy and Therapeutic Committee at AHF.
› Verified 7 days ago
Transcendent Healthcare Of Boonville Location: 725 S Second St, Boonville, Indiana 47601 Phone: (812) 897-1375 | |
Transcendent Healthcare Of Boonville - North Location: 305 E North St, Boonville, Indiana 47601 Phone: (812) 897-2810 |